Proceeds of $2.3 million from warrant exercises were reported. The company anticipates updates on the rat contraception program from New York City soon. Evolv's international expansion efforts include significant orders in the Netherlands, Hong Kong, and upcoming registrations in Australia, New Zealand, and other countries.